Citation

89 FR 95219

Canonical document for this Federal Register citation.

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; KEBILIDI (eladocagene exuparvovec-tneq) Monday, December 2, 2024 89 FR 95219